Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.

Lung cancer (Amsterdam, Netherlands) - 1 Oct 2011

Wagner Patrick L, Stiedl Ann-Cathrin, Wilbertz Theresia, Petersen Karen, Scheble Veit, Menon Roopika, Reischl Markus, Mikut Ralf, Rubin Mark A, Fend Falko, Moch Holger, Soltermann Alex, Weder Walter, Altorki Nasser K, Perner Sven

Abstract excerpt

BACKGROUND: Characterization of the non-small cell lung cancer (NSCLC) genome has suggested that KRAS amplification is one of the commonest molecular abnormalities in NSCLC. However, the prevalence and clinicopathologic significance of KRAS amplification, and its relationship with KRAS activating mutations have not been well-defined. The purpose of this study was to establish the prevalence of KRAS amplification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Population Groups

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Survival Analysis

Share to Switzerland

Share to United States

Source

Identifiers

PMID: 21477882
DOI: 10.1016/j.lungcan.2011.01.029

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.PMID 21477882Read ↗

Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients.Semantic proximity Read ↗

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.Semantic proximity Read ↗

KRAS mutations in lung cancer.Semantic proximity Read ↗

KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy.Semantic proximity Read ↗

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysSemantic proximity Read ↗

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.Semantic proximity Read ↗

Correlation of EGFR gene amplification with invasion and metastasis of non-small cell lung cancer.Semantic proximity Read ↗

Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.Semantic proximity Read ↗

Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura.Semantic proximity Read ↗

Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.Semantic proximity Read ↗

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populationsSemantic proximity Read ↗

Amplification of chromosomal segment 4q12 in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.